THSD3 activators include a spectrum of chemical entities that exert their influence on a variety of cellular processes, thereby increasing the activity of this particular protein. Activation of THSD3 is achieved through the modulation of intracellular signaling pathways that are either directly or indirectly involved in the protein's regulation. For instance, certain activators target adenylyl cyclase to boost cAMP levels within cells, culminating in the activation of PKA. PKA, in turn, phosphorylates THSD3, thereby increasing its activity. Another group of activators operates through the modulation of calcium levels within cells, which is pivotal for the activation of calcium-dependent proteins and signaling cascades, ultimately affecting the activity of THSD3. These mechanisms ensure that THSD3 is activated in a context-dependent manner, integrating multiple signaling cues to modulate its function.
Furthermore, THSD3 activity can be indirectly influenced by manipulations in the cellular signaling landscape. Inhibitors of specific kinases and phosphatases lead to an altered phosphorylation status of proteins within the cell, which may result in the enhanced activity of THSD3. Additionally, other activators intervene in lipid-mediated signaling, where they engage G protein-coupled receptors, altering kinase activities to favor the activation of THSD3. Moreover, interactions with multiple signaling pathways, including those regulated by NF-κB and PI3K, can create a cellular context conducive to THSD3 activation, even in the face of broad pathway inhibition. Lastly, activators that influence stress-responsive pathways and energy-sensing mechanisms can also modify the cellular milieu in a manner that promotes THSD3 activation, ensuring that the protein's activity is finely tuned in response to the cell's metabolic state and external stimuli.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and activate THSD3 by modulating signaling pathways that THSD3 is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
As a calcium ionophore, ionomycin increases intracellular calcium concentrations, activating calcium-dependent proteins and signaling pathways that can lead to THSD3 activation. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
This cAMP analogue activates PKA, leading to phosphorylation and potential activation of THSD3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates beta-adrenergic receptors, increasing cAMP and activating PKA, which may phosphorylate and activate THSD3. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Modulates signaling pathways associated with stress responses, potentially leading to the activation of THSD3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Activates PKA, which can phosphorylate and activate THSD3. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases, leading to sustained phosphorylation and potential activation of THSD3. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Activates G protein-coupled receptors and downstream kinases that can phosphorylate and activate THSD3. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 alters NF-κB activity, which can indirectly influence THSD3 activity through changes in signaling networks. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits PI3K, potentially leading to compensatory activation of signaling pathways that activate THSD3. | ||||||